Sanofi Can't Halt Amgen's Cholesterol Drug Sales At UPC
Sanofi and Regeneron have lost their attempt to prevent Amgen from selling cholesterol drug Repatha in Europe, failing to convince the Unified Patent Court that the medicine infringes their patent over...To view the full article, register now.
Already a subscriber? Click here to view full article